The Nurse View: Spotlight on EGFR-Mutated NSCLC

Slides:



Advertisements
Similar presentations
Upfront Combination Therapy vs Step-Up Approach for PAH:
Advertisements

Rosell R et al. Proc ASCO 2011;Abstract 7503.
Individualizing Treatment Options in Advanced ER-Positive Breast Cancer.
Introduction. TREATMENT BASED ON TUMOR SIDEDNESS IN mCRC: THE EVIDENCE AND PRACTICAL APPLICATION.
CDK 4 and 6 Inhibitors in HR-Positive Breast Cancer: Implementing Paradigms in Clinical Practice.
Patient Case 1 Patient Case 1: PET/CT Scan.
The Nurse View: Hormone Receptor-Positive Advanced Breast Cancer
Strategies for the Management of EGFR TKI Resistance in Advanced NSCLC
Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.
Advanced NSCLC Without Actionable Mutations
Fundamental Concepts in the Diagnosis of Advanced NSCLC
Assessing the Impact: New Data in T790+ NSCLC
The Nurse View.
New Patient Journeys in Non-small cell lung cancer
Progression After Cancer Immunotherapy in Advanced NSCLC
Modern Strategies for Basal Insulin Use in T2D
Spotlight on Immuno-Oncology in Melanoma
Updates and Perspectives on Third-Generation EFGR TKIs in Advanced NSCLC.
The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.
The Nurse View: Updates in the Management of Metastatic Colorectal Cancer.
Optimizing Outcomes in the Management of GIST
Introduction. For Pulmonologists by Pulmonologists: Diagnosis of NSCLC in an Age of Biomarkers.
Clinical Considerations in Evidence-based Management of GIST
THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES
Best Practices in Chronic Myeloid Leukemia by Multidisciplinary Teams
Novel and Emerging Approaches to Treating CLL
T790M Mutation-Positive NSCLC: A Multidisciplinary Case Conference
Liquid Biopsy for RAS Screening in CRC: How Can We Successfully Implement This New Paradigm?
Precision Management of RA and Comorbidities
Optimizing Management of Advanced Bladder Cancer
Checkpoint Inhibition
The Nurse View: Top Ten Things to Know About Immune-Mediated Adverse Events.
Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.
Exploring Personalized Prophylaxis in Hemophilia A
Managing Adverse Events With New Oral Therapies in CLL
Optimizing Outcomes and Managing Adverse Events in CLL
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
Serum vs FNA:.
Managing Polycythemia Vera in the Community Setting
When to Start and What to Use
Immune Checkpoint Inhibitors in Lung Cancer
Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Patient-Centered Management in Advanced Non-Small Cell Lung Cancer
All for One: Multidisciplinary Management in EGFR-Mutated NSCLC
Practical Guidance on the Management of Pan-Negative NSCLC
Challenges in LA SCCHN.
Practical Strategies to Guideline-Recommended Biomarker Testing in NSCLC.
This program will include a discussion of off-label treatment and investigational agents not approved by the Food and Drug Administration for use in the.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.
The Patient With Early Stage MF-CTCL
Multidisciplinary Management in Non-Small Cell Lung Cancer (NSCLC)
Optimizing Characterization of NSCLC Through Specialty Collaboration
Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC
The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.
THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES
Quality Improvement and Molecular Profiling in Advanced Non-Small Cell Lung Cancer.
Getting PPG Under Control
Third-Generation EGFR TKIs
Clinical Considerations in Evidence-based Management of GIST
The Changing Goals of CML Therapy
Finding the Right Sequence in Patients With EGFR-Mutated NSCLC
Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.
New Options for the Treatment of Hepatocellular Carcinoma
What's on the Horizon in the Management of EGFR-Mutated Lung Cancer?
Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.
The Nurse View.
The Nurse View: Practice Pearls in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC.
Updates in Best Practices in Non-Small Cell Lung Cancer
What's New in NOACs in AF?.
Presentation transcript:

The Nurse View: Spotlight on EGFR-Mutated NSCLC

An Introduction to EGFR TKIs

Molecular Testing in NSCLC

Tissue vs Liquid Biopsy

Best Practices Once Treatment Is Selected

Patient Case

Recognition and Prevention of Rash

Treatment of Rash

Patient Case Continued

Recognition and Management of Diarrhea

EGFR TKI Dose Adjustments

Additional AEs With EGFR TKIs

Grading AEs to Aid Management

Patient Case: Progression

Second-Line EGFR TKI Therapy

Cardiac Events

Pneumonitis

Concluding Remarks

Abbreviations

Abbreviations (cont)

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.